The NIEHS knock out core (KOC) is a servicing core facility with some research opportunity. Each project in the core is a long-term commitment from start to finish, and several projects are at different stages of completion in the core at any given time of the year. The core works very closely with the investigator since the inception of the project, which typically starts with meeting with PI's group for developing the targeting strategy and continues until the mutant mouse is made. KOC helps investigators to generate the mutant mouse customized to their research needs;including traditional knockouts, conditional knockout and knock-ins. It also provides assistance to establish and culturing the mutant cells for in vitro studies, along with dissecting the early stage embryos and help establishing the genotyping strategies.
Development of mouse models to determine the function of a gene or to identify the environmental effect on a disease process is the most effective way to move forward and identify the possible therapeutics to prevent or to slow down a disease process. The mouse models we develop in the KOC are used primarily to determine the function of a gene, the regulation of a gene, to determine the significance of a particular motif or a domain or using the mutant mouse to the environmental toxicants and determine the susceptibility of the mutant animals towards the environmental pollutants. For example, we identified abnormal glucose metabolism in heterozygous mutant mice for a type 1 BMP receptor (Alk3) and working on identifying the downstream target genes to find out the molecular mechanism of this abnormality. This information could potentially be important towards the greater good of human life and may add values for improving quality of human lives. In summary, the mutant mouse models we develop in the NIEHS KOC are potentially vital tools to improve the human health quality and to identify the target genes and the potential therapeutics to prevent serious illnesses.
|Edin, Matthew L; Hamedani, Behin Gholipour; Gruzdev, Artiom et al. (2018) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia. J Biol Chem 293:3281-3292|
|Martin, Negin P; Myers, Page; Goulding, Eugenia et al. (2018) En masse lentiviral gene delivery to mouse fertilized eggs via laser perforation of zona pellucida. Transgenic Res 27:39-49|
|Scott, Gregory J; Gruzdev, Artiom; Hagler, Thomas B et al. (2018) Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates. J Vis Exp :|
|Ungewitter, Erica K; Rotgers, Emmi; Kang, Hong Soon et al. (2018) Loss of Glis3 causes dysregulation of retrotransposon silencing and germ cell demise in fetal mouse testis. Sci Rep 8:9662|
|Stefkovich, Megan L; Arao, Yukitomo; Hamilton, Katherine J et al. (2018) Experimental models for evaluating non-genomic estrogen signaling. Steroids 133:34-37|
|House, John S; Nichols, Cody E; Li, Huiling et al. (2017) Vagal innervation is required for pulmonary function phenotype in Htr4(-/-) mice. Am J Physiol Lung Cell Mol Physiol 312:L520-L530|
|Coons, Laurel A; Hewitt, Sylvia C; Burkholder, Adam B et al. (2017) DNA Sequence Constraints Define Functionally Active Steroid Nuclear Receptor Binding Sites in Chromatin. Endocrinology 158:3212-3234|
|Kang, Hong Soon; Kumar, Dhirendra; Liao, Grace et al. (2017) GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation. J Clin Invest 127:4326-4337|
|Jerschow, Elina; Edin, Matthew L; Pelletier, Teresa et al. (2017) Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract 5:998-1007.e2|
|Plummer, Nicholas W; Ungewitter, Erica K; Smith, Kathleen G et al. (2017) A new mouse line for cell ablation by diphtheria toxin subunit A controlled by a Cre-dependent FLEx switch. Genesis 55:|
Showing the most recent 10 out of 56 publications